Terms: = Kidney tumors AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1
222 results:
1. Clinical Efficacy of Bushen Yiqi Fuzheng Decoction Combined with Sunitinib in the Treatment of Postoperative Patients with Renal Cell Carcinoma and Its Influence on Their Immune Function.
Zhang L; Liu L; Zhao L; Yuan X; Wang Y; Yang J
Arch Esp Urol; 2023 Sep; 76(7):538-547. PubMed ID: 37867340
[TBL] [Abstract] [Full Text] [Related]
2. timp1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
[TBL] [Abstract] [Full Text] [Related]
3. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic role of the immunohistochemical expression of proteins related to the renin-angiotensin system pathway in nonmetastatic clear cell renal cell carcinoma.
Mourão TC; Bezerra SM; de Almeida E Paula F; Rocha MM; Santos VE; Brazão Junior ES; Abreu D; da Costa WH; Zequi SC
Urol Oncol; 2023 Aug; 41(8):359.e1-359.e13. PubMed ID: 37286405
[TBL] [Abstract] [Full Text] [Related]
5. Berberine inhibits the progression of renal cell carcinoma cells by regulating reactive oxygen species generation and inducing DNA damage.
Zhao Y; Lin X; Zeng W; Qin X; Miao B; Gao S; Liu J; Li Z
Mol Biol Rep; 2023 Jul; 50(7):5697-5707. PubMed ID: 37217616
[TBL] [Abstract] [Full Text] [Related]
6. Polycythemia Secondary to Renal Hemangioblastoma: A Case Report and Literature Review.
Lee Y; Cheng SM; Hwang DY; Chiu YL; Chou YH
Int J Surg Pathol; 2024 Feb; 32(1):140-144. PubMed ID: 37150964
[TBL] [Abstract] [Full Text] [Related]
7. The Role of HIF1-related Genes and Non-coding RNAs Expression in Clear Cell Renal Cell Carcinoma.
Grammatikaki S; Katifelis H; Stravodimos K; Bakolas E; Kavantzas N; Grigoriadou D; Gazouli M
In Vivo; 2023; 37(3):1103-1110. PubMed ID: 37103094
[TBL] [Abstract] [Full Text] [Related]
8. Roxadustat and its failure: A comparative dynamic study.
Gul K; Zaman N; Azam SS
J Mol Graph Model; 2023 May; 120():108422. PubMed ID: 36708643
[TBL] [Abstract] [Full Text] [Related]
9. Iron metabolism abnormalities in autoimmune hemolytic anemia and
Zhao M; Wang Y; Yang J; Wang Y; Feng Y; Chen L; Shao Z; Wang H; Xing L
Ann Med; 2023 Dec; 55(1):231-240. PubMed ID: 36576329
[TBL] [Abstract] [Full Text] [Related]
10. Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma.
Ye J; Li P; Zhang H; Wu Q; Yang D
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360294
[TBL] [Abstract] [Full Text] [Related]
11. THE JEREMIAH METZGER LECTURE:VON HIPPEL-LINDAU DISEASE: INSIGHTS INTO OXYGEN SENSING, CANCER AND DRUGGING THE UNDRUGGABLE.
Kaelin WG
Trans Am Clin Climatol Assoc; 2022; 132():170-181. PubMed ID: 36196173
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of miRNA-21 and blood Cr levels with tumor infiltration and distant metastasis in renal cancer patients.
Li H; Qu L
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(5):117-123. PubMed ID: 36029501
[TBL] [Abstract] [Full Text] [Related]
13. Risk assessment for PFOA and kidney cancer based on a pooled analysis of two studies.
Steenland K; Hofmann JN; Silverman DT; Bartell SM
Environ Int; 2022 Sep; 167():107425. PubMed ID: 35905598
[TBL] [Abstract] [Full Text] [Related]
14. Resveratrol Nanoparticles Suppresses Migration and Invasion of Renal Cell Carcinoma Cells by Inhibiting Matrix Metalloproteinase 2 Expression and Extracellular Signal-Regulated Kinase Pathway.
Zhu XW; Dong FM; Liu J; Li MS
J Biomed Nanotechnol; 2022 Apr; 18(4):1001-1008. PubMed ID: 35854457
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer.
Qu G; Wang H; Tang C; Yang G; Xu Y
Dis Markers; 2022; 2022():4761803. PubMed ID: 35655917
[TBL] [Abstract] [Full Text] [Related]
16. Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Armstrong AJ; Nixon AB; Carmack A; Yang Q; Eisen T; Stadler WM; Jones RJ; Garcia JA; Vaishampayan UN; Picus J; Hawkins RE; Hainsworth JD; Kollmannsberger CK; Logan TF; Puzanov I; Pickering LM; Ryan CW; Protheroe A; George DJ; Halabi S
Clin Cancer Res; 2021 Jun; 27(12):3317-3328. PubMed ID: 33593885
[TBL] [Abstract] [Full Text] [Related]
17. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
Satu MS; Khan MI; Rahman MR; Howlader KC; Roy S; Roy SS; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1415-1429. PubMed ID: 33539530
[TBL] [Abstract] [Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors have adverse effects in anti-angiogenesis therapy for hepatocellular carcinoma.
Zhang S; Cao M; Hou Z; Gu X; Chen Y; Chen L; Luo Y; Chen L; Liu D; Zhou H; Zhu K; Wang Z; Zhang X; Zhu X; Cui Y; Li H; Guo H; Zhang T
Cancer Lett; 2021 Mar; 501():147-161. PubMed ID: 33383154
[TBL] [Abstract] [Full Text] [Related]
19. Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma.
Lee CH; Motzer RJ; Glen H; Michaelson MD; Larkin J; Minoshima Y; Kanekiyo M; Ikezawa H; Sachdev P; Dutcus CE; Funahashi Y; Voss MH
Br J Cancer; 2021 Jan; 124(1):237-246. PubMed ID: 33024271
[TBL] [Abstract] [Full Text] [Related]
20. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract] [Full Text] [Related]
[Next]
